688180 君实生物
2024/03 - 三个月
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
经营活动产生之现金流量净额(376,578)(2,004,982)(1,776,201)(605,050)(1,456,377)
投资活动产生之现金流量净额(73,270)(933,191)(437,213)(1,917,802)(740,407)
筹资活动产生之现金流量净额1,219,839711,8284,613,4782,665,6864,413,523
汇率变动对现金及现金等价物的影响1,2507,55192,266(23,226)(45,768)
现金及现金等价物净增加/(减少)771,240(2,218,794)2,492,331119,6072,170,972
期初现金及现金等价物余额3,778,1425,996,9363,504,6053,384,9981,214,026
期末现金及现金等价物余额4,549,3823,778,1425,996,9363,504,6053,384,998